Lemaitre Vascular (LMAT) Depreciation & Amortization (CF) (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 2.78% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 7.27% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 8.43% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $2.6 million, up from $2.6 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for LMAT reached as high as $2.6 million in Q2 2025 and fell as low as $2.3 million in Q4 2022.
• Historically, Depreciation & Amortization (CF) has averaged $2.4 million across 5 years, with a median of $2.4 million in 2024.
• Across the five-year window, Depreciation & Amortization (CF) dropped 20.67% in 2022 and increased 11.07% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $2.3 million in 2022, then rose by 6.77% to $2.4 million in 2023, then retreated by 1.11% to $2.4 million in 2024, then gained by 7.82% to $2.6 million in 2025, then rose by 0.69% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.